Mahima Datla, BP Acharya to receive FABA 2022 awards
Hyderabad: Federation of Asian Biotech Associations [FABA] has announced the recipients of this year’s awards. Dr B S Bajaj Memorial FABA Special Award-2022 will be conferred upon Mahima Datla, MD, Biological E for introducing Corbevax vaccine in augmenting the fight against Covid-19 and B P Acharya, patron, FABA has been selected for the FABA Lifetime […]
Hyderabad: Federation of Asian Biotech Associations [FABA] has announced the recipients of this year’s awards.
Dr B S Bajaj Memorial FABA Special Award-2022 will be conferred upon Mahima Datla, MD, Biological E for introducing Corbevax vaccine in augmenting the fight against Covid-19 and B P Acharya, patron, FABA has been selected for the FABA Lifetime Achievement Award for his contributions to AIBA (All India Biotech Associations) and FABA.
The awards will be conferred during the 19th edition of BioAsia, the largest annual global biotechnology and life sciences summit of Asia, organised by the Government of Telangana and FABA.
Announcing the award, professor Reddanna, executive president, FABA, said, “The Dr B S Bajaj Memorial Award is a distinction bestowed on the individual or organisation most committed to the advancement of life sciences. The contributions made by Biological E under the able leadership of Mahima Datla are conscientiously recognised and commended by the biotechnology fraternity. Their vaccine, Corbevax being scalable and affordable to the low-middle income countries, makes Biological E the most promising candidate for this award.”
B P Acharya has been serving as advisor to ICMR for the National Animal Resource Facility for Biomedical Research (NARFBR) after his retirement from MHRD in 2020. Acharya coordinated the significant initiatives of Government of Andhra Pradesh to develop Genome Valley and biotech sector in the region.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
